Scarica l'app Stockscreener
0.99
1.02%
0.01
Dopo l'orario di chiusura:
.99
Precedente Chiudi:
$0.98
Aprire:
$0.98
Volume 24 ore:
106.47K
Relative Volume:
0.44
Capitalizzazione di mercato:
$37.58M
Reddito:
$63.15M
Utile/perdita netta:
$-40.30M
Rapporto P/E:
-0.5928
EPS:
-1.67
Flusso di cassa netto:
$-44.47M
1 W Prestazione:
+4.21%
1M Prestazione:
-1.98%
6M Prestazione:
-67.43%
1 anno Prestazione:
-82.99%
Intervallo 1D:
$0.9501
$1.0682
Intervallo di 1 settimana:
$0.94
$1.14
Portata 52W:
$0.8645
$6.50
Tela Bio Inc Stock (TELA) Company Profile
Nome
Tela Bio Inc
Settore
Industria
Telefono
484-320-2930
Indirizzo
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Confronta TELA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
0.99 | 37.58M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
128.56 | 233.05B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.95 | 155.05B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
386.32 | 146.77B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
84.25 | 106.66B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
76.75 | 44.02B | 5.54B | 4.18B | 623.10M | 7.00 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Iniziato | Lake Street | Buy |
| 2019-12-03 | Iniziato | Canaccord Genuity | Buy |
| 2019-12-03 | Iniziato | JMP Securities | Mkt Outperform |
| 2019-12-03 | Iniziato | Jefferies | Buy |
| 2019-12-03 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Tela Bio Inc Borsa (TELA) Ultime notizie
TELA Bio Announces Inducement Grants to New Hires with 4-Year Vesting Plan - MSN
TELA Bio announces inducement grants - Medical Buyer
TELA Bio Reports Q1 2025 Growth and Product Expansion - MyChesCo
TELA Bio, Inc. (NASDAQ:TELA) Q1 2025 Earnings Call Transcript - Insider Monkey
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5 - GuruFocus
TELA Bio’s Earnings Call: Growth Amid Challenges - TipRanks
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | TELA Stock News - GuruFocus
TELA Bio revenue up 12% to USD 18.5 million in Q1 2025 - Medical Buyer
TELA Bio Inc (TELA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Challenges - Yahoo Finance
TELA Bio Inc (TELA) Q1 2025 Earnings Call Highlights: Strong Rev - GuruFocus
TELA Bio Reports Strong Q1 2025 Revenue Growth - TipRanks
TELA Bio Reports First Quarter 2025 Financial Results - GlobeNewswire
Earnings call transcript: Tela Bio Q1 2025 revenue miss, stock rises 9% - Investing.com India
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
TELA Bio Reports Q1 2025 Revenue Growth Amid Losses - TipRanks
TELA Bio Inc (TELA) Q1 2025 Earnings Report Preview: What to Expect - Yahoo Finance
Inspire Medical Systems (NYSE:INSP) & TELA Bio (NASDAQ:TELA) Critical Analysis - Defense World
TELA Bio Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
Short Interest in TELA Bio, Inc. (NASDAQ:TELA) Drops By 14.6% - Defense World
Favourable Signals For TELA Bio: Numerous Insiders Acquired Stock - Yahoo Finance
JPMorgan Chase & Co. Increases Stock Holdings in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
Geode Capital Management LLC Buys 136,890 Shares of TELA Bio, Inc. (NASDAQ:TELA) - Defense World
Renaissance Technologies LLC Has $1.28 Million Stake in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
Critical Analysis: TELA Bio (NASDAQ:TELA) & Retractable Technologies (NYSE:RVP) - Defense World
TELA Bio Inc (TELA) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges with ... - Yahoo
TELA Bio Inc (TELA) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges with Strategic Initiatives - GuruFocus
TELA Bio to Announce Q1 2025 Earnings on May 8 - MSN
TELA Bio to Announce First Quarter 2025 Financial Results | TELA Stock News - GuruFocus
TELA Bio to Announce First Quarter 2025 Financial Results - GlobeNewswire
TELA Bio, Inc. (NASDAQ:TELA) Stock Position Boosted by Commonwealth Equity Services LLC - Defense World
Prudential Financial Inc. Takes $57,000 Position in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
Tela Bio slumps after Q4 miss as Piper Sandler downgrades - MSN
TELA Bio Expands OviTex PRS Line with Larger Surgical Sizes - MSN
Canaccord maintains TELA Bio stock with $7 target post-challenges By Investing.com - Investing.com Canada
Canaccord maintains TELA Bio stock with $7 target post-challenges - Investing.com
Tela Bio stock plunges to 52-week low of $1.13 amid market challenges - Investing.com Canada
Not Many Are Piling Into TELA Bio, Inc. (NASDAQ:TELA) Stock Yet As It Plummets 50% - simplywall.st
TELA Bio introduces larger sizes for soft tissue reconstruction - Investing.com India
TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery - GlobeNewswire
Revolutionary Expansion: TELA Bio's New OviTex PRS Sizes Set Industry Record as Sales Surge 31% - Stock Titan
TELA Bio’s Earnings Call: Challenges and Optimism for 2025 - MSN
TELA Bio (NASDAQ:TELA) Cut to “Neutral” at Piper Sandler - The AM Reporter
TELA Bio Announces 2024 Financial Results and Positive 2025 Outlook - MSN
Tela Bio Inc Azioni (TELA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.22%
2.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):